The effects of NKT cell-mediated immunotherapy by IDO inhibitor in mouse lung metastasis model
Project/Area Number |
26860376
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Laboratory medicine
|
Research Institution | Fujita Health University (2016) Suzuka University of Medical Science (2014-2015) |
Principal Investigator |
Hoshi Masato 藤田保健衛生大学, 医療科学部, 講師 (40633996)
|
Research Collaborator |
SEISHIMA Mitsuru
SAITO Kuniaki
ITO Hiroyasu
HARA Akira
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | インドールアミン酸素添加酵素1 / インドールアミン酸素添加酵素2 / トリプトファン代謝産物 / B16F10細胞 / 抗腫瘍効果 / 細胞免疫療法 / IDO1 / IDO2 / B16F10 / IDO1 / IDO2 / B16F10 / α-ガラクトシルセラミド / トリプトファン代謝 / 1-MT / IDO / B16細胞 / α-ガラクトシルセラミド / トリプタファン代謝 / 1-metyl-D-tryptophan / 1-metyl-L-tryptophan |
Outline of Final Research Achievements |
The role of indoleamine 2,3-dioxygenase (Ido) in the L-tryptophan (Trp)-kynurenine (Kyn) pathway after lung metastasis model by injecting B16F10 cells was investigated. We used α-GalCer administrated mice of wild type (WT), IDO1 KO, IDO2 KO, and mice treated with 1-methyl-D or L-tryptophan (D or L-1MT), an inhibitor of Ido1 or Ido2 respectively, to study the importance of Trp-Kyn pathway metabolites. The levels of Ido1 and Ido2 mRNA and protein expression in the lung from WT mice were significantly higher than those from non-injected WT mice. The anti-tumor effect in the lung from IDO1 KO mice or L-1MT treated mice was markedly improved compared to that in WT mice, IDO2 KO mice, and D-1MT treated mice. Moreover, the levels of Trp metabolites in lung from IDO1 KO mice or L-1MT treated mice was significantly decreased compared to that in lung from WT mice, IDO2 KO mice, and D-1MT treated mice.
|
Report
(4 results)
Research Products
(12 results)
-
-
[Journal Article] Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.2015
Author(s)
Takamatsu M, Hirata A, Ohtaki H, Hoshi M, Ando T, Ito H, Hatano Y, Tomita H, Kuno T, Saito K, Seishima M, Hara A.
-
Journal Title
Cancer Sci.
Volume: 106(8)
Issue: 8
Pages: 1008-15
DOI
NAID
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
[Journal Article] Kynurenine production mediated by indoleamine 2, 3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis2014
Author(s)
Ohtaki H, Ito H, Ando K, Ishikawa T, Hoshi M, Ando T, Takamatsu M, Hara A, Moriwaki H, Saito K, Seishima M
-
Journal Title
Biochim Biophys Acta
Volume: 1842(9)
Issue: 9
Pages: 1464-71
DOI
Related Report
Peer Reviewed
-
[Journal Article] Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis2014
Author(s)
Taguchi A, Niwa M, Hoshi M, Saito K, Masutani T, Hisamatsu K, Kobayashi K, Hatano Y, Tomita H, Hara A
-
Journal Title
Neurosci Lett
Volume: 3564
Pages: 120-5
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-